Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

The clinico-pathological spectrum of primary cutaneous lymphoma other than mycosis fungoides/Sezary syndrome.

Oschlies I, King RL, Dotlic S, Montes-Moreno S, Ponzoni M, Traverse-Glehen A, Calaminici M, Ferry JA, Ott G, Goodlad JR.

Virchows Arch. 2019 Nov 28. doi: 10.1007/s00428-019-02713-7. [Epub ahead of print] Review.

PMID:
31781845
2.

Update on lymphoproliferative disorders of the gastrointestinal tract: disease spectrum from indolent lymphoproliferations to aggressive lymphomas.

Moreno SM, King RL, Oschlies I, Ponzoni M, Goodlad JR, Dotlic S, Traverse-Glehen A, Ott G, Ferry JA, Calaminici M.

Virchows Arch. 2019 Nov 26. doi: 10.1007/s00428-019-02704-8. [Epub ahead of print] Review.

PMID:
31773249
3.

The broad and challenging landscape of extranodal lymphoproliferations.

Dotlic S, Ponzoni M, King RL, Oschlies I, Ferry J, Calaminici M, Montes-Moreno S, Goodlad JR, Ott G, Traverse-Glehen A.

Virchows Arch. 2019 Nov 22. doi: 10.1007/s00428-019-02702-w. [Epub ahead of print]

PMID:
31758317
4.

A case of idiopathic multicentric Castleman disease in an alemtuzumab-treated patient with MS.

Rolfes L, Pfeuffer S, Ruck T, Windhagen S, Oschlies I, Pavenstädt HJ, Angenendt L, Wiendl H, Krämer J, Meuth SG.

Neurol Neuroimmunol Neuroinflamm. 2019 Nov 8;7(1). pii: e638. doi: 10.1212/NXI.0000000000000638. Print 2020 Jan. No abstract available. Erratum in: Neurol Neuroimmunol Neuroinflamm. 2019 Dec 5;7(1):.

5.

Quantification of minimal disseminated disease by quantitative PCR and digital PCR for NPM-ALK as prognostic factor in children with anaplastic large cell lymphoma.

Damm-Welk C, Kutscher N, Zimmermann M, Attarbaschi A, Schieferstein J, Knörr F, Oschlies I, Klapper W, Woessmann W.

Haematologica. 2019 Oct 24. pii: haematol.2019.232314. doi: 10.3324/haematol.2019.232314. [Epub ahead of print]

6.

Cryptic insertion of MYC exons 2 and 3 into the IGH locus detected by whole genome sequencing in a case of MYC-negative Burkitt lymphoma.

Wagener R, Bens S, Toprak UH, Seufert J, López C, Scholz I, Herbrueggen H, Oschlies I, Stilgenbauer S, Schlesner M, Klapper W, Burkhardt B, Siebert R.

Haematologica. 2019 May 9. pii: haematol.2018.208140. doi: 10.3324/haematol.2018.208140. [Epub ahead of print]

7.

[Hematological neoplasias as differential diagnoses of soft tissue tumors].

Koch K, Reddemann K, Klapper W, Oschlies I.

Pathologe. 2019 Jul;40(4):412-421. doi: 10.1007/s00292-019-0588-1. German.

PMID:
30941488
8.

AL amyloidosis with a localized B cell neoplasia.

Stuhlmann-Laeisz C, Schönland SO, Hegenbart U, Oschlies I, Baumgart JV, Krüger S, Röcken C.

Virchows Arch. 2019 Mar;474(3):353-363. doi: 10.1007/s00428-019-02527-7. Epub 2019 Jan 24.

PMID:
30680453
9.

Programmed cell death protein1 (PD1)-expression in the microenvironment of classical Hodgkin lymphoma at relapse after conventional chemotherapy and at relapse on anti-PD1 treatment.

Sasse S, Reddemann K, Diepstra A, Borchmann S, Oschlies I, Schnitter A, Engert A, Borchmann P, Klapper W.

Haematologica. 2019 Jan;104(1):e45-e46. doi: 10.3324/haematol.2018.207829. No abstract available.

10.

Non-leukemic pediatric mixed phenotype acute leukemia/lymphoma: Genomic characterization and clinical outcome in a prospective trial for pediatric lymphoblastic lymphoma.

Martin-Guerrero I, Salaverria I, Burkhardt B, Chassagne-Clement C, Szczepanowski M, Bens S, Klapper W, Zimmermann M, Kabickova E, Bertrand Y, Reiter A, Siebert R, Oschlies I.

Genes Chromosomes Cancer. 2019 Jun;58(6):365-372. doi: 10.1002/gcc.22726. Epub 2019 Jan 21.

PMID:
30578714
11.

IG-MYC + neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas.

Wagener R, López C, Kleinheinz K, Bausinger J, Aukema SM, Nagel I, Toprak UH, Seufert J, Altmüller J, Thiele H, Schneider C, Kolarova J, Park J, Hübschmann D, Murga Penas EM, Drexler HG, Attarbaschi A, Hovland R, Kjeldsen E, Kneba M, Kontny U, de Leval L, Nürnberg P, Oschlies I, Oscier D, Schlegelberger B, Stilgenbauer S, Wössmann W, Schlesner M, Burkhardt B, Klapper W, Jaffe ES, Küppers R, Siebert R.

Blood. 2018 Nov 22;132(21):2280-2285. doi: 10.1182/blood-2018-03-842088. Epub 2018 Oct 3.

12.

Skin involvement by chronic lymphocytic leukaemia is frequently associated with unrelated neoplastic or inflammatory cutaneous disease and is not indicative of general disease progression.

Thiesen I, Wehkamp U, Brüggemann M, Ritgen M, Murga Penas EM, Klapper W, Oschlies I.

Br J Dermatol. 2019 Jan;180(1):227-228. doi: 10.1111/bjd.17135. Epub 2018 Oct 25. No abstract available.

PMID:
30183072
13.

Programmed cell death protein-1 (PD-1)-expression in the microenvironment of classical Hodgkin lymphoma at relapse during anti-PD-1-treatment.

Sasse S, Reddemann K, Diepstra A, Oschlies I, Schnitter A, Borchmann S, Engert A, Borchmann P, Klapper W.

Haematologica. 2019 Jan;104(1):e21-e24. doi: 10.3324/haematol.2018.196279. Epub 2018 Aug 3. No abstract available.

14.

Round-robin test for the cell-of-origin classification of diffuse large B-cell lymphoma-a feasibility study using full slide staining.

Reinke S, Richter J, Fend F, Feller A, Hansmann ML, Hüttl K, Oschlies I, Ott G, Möller P, Rosenwald A, Stein H, Altenbuchinger M, Spang R, Klapper W.

Virchows Arch. 2018 Sep;473(3):341-349. doi: 10.1007/s00428-018-2367-4. Epub 2018 May 5.

PMID:
29730836
15.

Clinically defined subgroups of mycosis fungoides display differing histopathological features at initial biopsy.

Wehkamp U, Weichenthal M, Egberts F, Schwarz T, Klapper W, Oschlies I.

Leuk Lymphoma. 2018 Dec;59(12):2871-2879. doi: 10.1080/10428194.2018.1452218. Epub 2018 Apr 4.

PMID:
29616855
16.

S2k-Leitlinie - Kutane Lymphome Update 2016 - Teil 2: Therapie und Nachsorge (ICD10 C82 - C86).

Dippel E, Assaf C, Becker JC, von Bergwelt-Baildon M, Beyer M, Cozzio A, Eich HT, Follmann M, Grabbe S, Hillen U, Klapper W, Klemke CD, Lamos C, Loquai C, Meiß F, Mestel D, Nashan D, Nicolay JP, Oschlies I, Schlaak M, Stoll C, Vag T, Weichenthal M, Wobser M, Stadler R.

J Dtsch Dermatol Ges. 2018 Jan;16(1):112-123. doi: 10.1111/ddg.13401_g. No abstract available.

PMID:
29314698
17.

S2k Guidelines - Cutaneous Lymphomas Update 2016 - Part 2: Treatment and Follow-up (ICD10 C82 - C86).

Dippel E, Assaf C, Becker JC, von Bergwelt-Baildon M, Beyer M, Cozzio A, Eich HT, Follmann M, Grabbe S, Hillen U, Klapper W, Klemke CD, Lamos C, Loquai C, Meiß F, Mestel D, Nashan D, Nicolay JP, Oschlies I, Schlaak M, Stoll C, Vag T, Weichenthal M, Wobser M, Stadler R.

J Dtsch Dermatol Ges. 2018 Jan;16(1):112-122. doi: 10.1111/ddg.13401. Epub 2017 Dec 27. No abstract available.

PMID:
29280595
18.

S2k-Leitlinie - Kutane Lymphome Update 2016 - Teil 1: Klassifikation und Diagnostik (ICD10 C82 - C86).

Dippel E, Assaf C, Becker JC, von Bergwelt-Baildon M, Beyer M, Cozzio A, Eich HT, Follmann M, Grabbe S, Hillen U, Klapper W, Klemke CD, Lamos C, Loquai C, Meiß F, Mestel D, Nashan D, Nicolay JP, Oschlies I, Schlaak M, Stoll C, Vag T, Weichenthal M, Wobser M, Stadler R.

J Dtsch Dermatol Ges. 2017 Dec;15(12):1266-1273. doi: 10.1111/ddg.13372_g. No abstract available.

PMID:
29228489
19.

S2k Guidelines - Cutaneous Lymphomas Update 2016 - Part 1: Classification and Diagnosis (ICD10 C82 - C86).

Dippel E, Assaf C, Becker JC, von Bergwelt-Baildon M, Beyer M, Cozzio A, Eich HT, Follmann M, Grabbe S, Hillen U, Klapper W, Klemke CD, Lamos C, Loquai C, Meiß F, Mestel D, Nashan D, Nicolay JP, Oschlies I, Schlaak M, Stoll C, Vag T, Weichenthal M, Wobser M, Stadler R.

J Dtsch Dermatol Ges. 2017 Dec;15(12):1266-1273. doi: 10.1111/ddg.13372. Epub 2017 Nov 28. No abstract available.

PMID:
29193659
20.

Excellent outcome with limited treatment in paediatric patients with marginal zone lymphoma.

Makarova O, Oschlies I, Müller S, Ruf S, Zimmermann M, Niggli F, Attarbaschi A, Kabickova E, Klapper W, Woessmann W, Burkhardt B.

Br J Haematol. 2018 Sep;182(5):735-739. doi: 10.1111/bjh.14868. Epub 2017 Aug 2. No abstract available.

PMID:
28771659
21.

Spindle-Cell Variants of Primary Cutaneous Follicle Center B-Cell Lymphomas Are Germinal Center B-Cell Lymphomas by Gene Expression Profiling Using a Formalin-Fixed Paraffin-Embedded Specimen.

Oschlies I, Kohler CW, Szczepanowski M, Koch K, Gontarewicz A, Metze D, Hillen U, Richter J, Spang R, Klapper W.

J Invest Dermatol. 2017 Nov;137(11):2450-2453. doi: 10.1016/j.jid.2017.06.016. Epub 2017 Jul 3. No abstract available.

22.

[Recovery of paraffin blocks and central archiving : Experiences of the Kiel lymph node registry and the German study group for Hodgkin lymphoma].

Čavčić M, Oschlies I, Fuchs M, Engert A, Klapper W.

Pathologe. 2017 Nov;38(6):529-534. doi: 10.1007/s00292-017-0321-x. German.

PMID:
28676898
23.

Unilesional locally recurrent lymphomatoid papulosis with variable histological presentation.

Wehkamp U, Weichenthal M, Klapper W, Schwarz T, Oschlies I.

Leuk Lymphoma. 2018 Jan;59(1):262-264. doi: 10.1080/10428194.2017.1323274. Epub 2017 May 31. No abstract available.

PMID:
28562138
24.

Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols.

Rohde M, Bonn BR, Zimmermann M, Lange J, Möricke A, Klapper W, Oschlies I, Szczepanowski M, Nagel I, Schrappe M; MMML-MYC-SYS Project; ICGC MMML-Seq Project, Loeffler M, Siebert R, Reiter A, Burkhardt B.

Haematologica. 2017 Jun;102(6):1091-1098. doi: 10.3324/haematol.2016.156885. Epub 2017 Feb 16.

25.

[Unilateral upper eyelid membrane in conjunctivitis lignosa].

Bauer M, Koinzer S, Oschlies I, Claviez A, Tiede K, Roider J, Nölle B.

Ophthalmologe. 2016 Oct;113(10):878. German. No abstract available.

PMID:
27638173
26.

Transient spontaneous remission in congenital MLL-AF10 rearranged acute myeloid leukemia presenting with cardiorespiratory failure and meconium ileus.

Gyárfás T, Wintgens J, Biskup W, Oschlies I, Klapper W, Siebert R, Bens S, Haferlach C, Meisel R, Kuhlen M, Borkhardt A.

Mol Cell Pediatr. 2016 Dec;3(1):30. doi: 10.1186/s40348-016-0061-7. Epub 2016 Aug 29.

27.

Anti-ALK Antibodies in Patients with ALK-Positive Malignancies Not Expressing NPM-ALK.

Damm-Welk C, Siddiqi F, Fischer M, Hero B, Narayanan V, Camidge DR, Harris M, Burke A, Lehrnbecher T, Pulford K, Oschlies I, Siebert R, Turner S, Woessmann W.

J Cancer. 2016 Jun 30;7(11):1383-7. doi: 10.7150/jca.15238. eCollection 2016.

28.

The t(11;14)(q13;q32)/CCND1-IGH translocation is a recurrent secondary genetic aberration in relapsed chronic lymphocytic leukemia.

Schliemann I, Oschlies I, Nagel I, Maria Murga Penas E, Siebert R, Sander B.

Leuk Lymphoma. 2016 Nov;57(11):2672-6. doi: 10.3109/10428194.2016.1153085. Epub 2016 Feb 25. No abstract available.

PMID:
26916968
29.

Alveolar rhabdomyosarcoma confined to the bone marrow with no identifiable primary tumour using FDG-PET/CT.

Karagiannis P, Guth N, Thoennissen GB, Bern C, Sperveslage J, Oschlies I, Bokemeyer C, Klapper W, Wardelmann E, Thoennissen NH.

Clin Sarcoma Res. 2015 Nov 19;5:24. doi: 10.1186/s13569-015-0039-6. eCollection 2015.

30.

[Histiocytic diseases in childhood and adolescence].

Vokuhl C, Oschlies I, Klapper W, Leuschner I.

Pathologe. 2015 Sep;36(5):443-50. doi: 10.1007/s00292-015-0043-x. Review. German.

PMID:
26292932
31.

Proposal of a genetic classifier for risk group stratification in pediatric T-cell lymphoblastic lymphoma reveals differences from adult T-cell lymphoblastic leukemia.

Balbach ST, Makarova O, Bonn BR, Zimmermann M, Rohde M, Oschlies I, Klapper W, Rössig C, Burkhardt B.

Leukemia. 2016 Apr;30(4):970-3. doi: 10.1038/leu.2015.203. Epub 2015 Jul 28. No abstract available.

PMID:
26216196
32.

[Ligneous conjunctivitis].

Bauer M, Koinzer S, Oschlies I, Claviez A, Tiede K, Roider J, Nölle B.

Ophthalmologe. 2016 May;113(5):416-9. doi: 10.1007/s00347-015-0097-4. German.

PMID:
26142234
33.

Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations.

Aukema SM, Theil L, Rohde M, Bauer B, Bradtke J, Burkhardt B, Bonn BR, Claviez A, Gattenlöhner S, Makarova O, Nagel I, Oschlies I, Pott C, Szczepanowski M, Traulsen A, Kluin PM, Klapper W, Siebert R, Murga Penas EM.

Br J Haematol. 2015 Sep;170(6):814-25. doi: 10.1111/bjh.13501. Epub 2015 Jun 24.

PMID:
26104998
34.

ALK-positive primary cutaneous T-cell-lymphoma (CTCL) with unusual clinical presentation and aggressive course.

Wehkamp U, Oschlies I, Nagel I, Brasch J, Kneba M, Günther A, Klapper W, Weichenthal M.

J Cutan Pathol. 2015 Nov;42(11):870-7. doi: 10.1111/cup.12547. Epub 2015 Jun 25.

PMID:
26053561
35.

Skin Involvement of Mantle Cell Lymphoma May Mimic Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type.

Wehkamp U, Pott C, Unterhalt M, Koch K, Weichenthal M, Klapper W, Oschlies I.

Am J Surg Pathol. 2015 Aug;39(8):1093-101. doi: 10.1097/PAS.0000000000000445.

PMID:
26034867
36.

In Europe expression of EBNA2 is associated with poor survival in EBV-positive diffuse large B-cell lymphoma of the elderly.

Stuhlmann-Laeisz C, Borchert A, Quintanilla-Martinez L, Hoeller S, Tzankov A, Oschlies I, Kreuz M, Trappe R, Klapper W.

Leuk Lymphoma. 2016;57(1):39-44. doi: 10.3109/10428194.2015.1040014.

PMID:
25899404
37.

Successful stem cell transplantation in a patient with primary cutaneous aggressive cytotoxic epidermotropic CD8+ T-cell lymphoma.

Wehkamp U, Glaeser D, Oschlies I, Hilgendorf I, Klapper W, Weichenthal M.

Br J Dermatol. 2015 Sep;173(3):869-71. doi: 10.1111/bjd.13792. Epub 2015 Jul 20. No abstract available.

PMID:
25816848
38.
39.

Reproducibility of Her2/neu scoring in gastric cancer and assessment of the 10% cut-off rule.

Behrens HM, Warneke VS, Böger C, Garbrecht N, Jüttner E, Klapper W, Mathiak M, Oschlies I, Rudolph U, Stuhlmann-Laeisz C, Trick D, Röcken C, Hufnagl P.

Cancer Med. 2015 Feb;4(2):235-44. doi: 10.1002/cam4.365. Epub 2014 Dec 16.

40.

Detection of EBV in reactive and neoplastic lymphoproliferations in adults-when and how?

Stuhlmann-Laeisz C, Oschlies I, Klapper W.

J Hematop. 2014 Jul 3;7(4):165-170. eCollection 2014 Dec. Review.

41.

Subcutaneous panniculitis-like T-cell lymphoma in children: a detailed clinicopathological description of 11 multifocal cases with a high frequency of haemophagocytic syndrome.

Oschlies I, Simonitsch-Klupp I, Maldyk J, Konovalov D, Abramov D, Myakova N, Lisfeld J, Attarbaschi A, Kontny U, Woessmann W, Klapper W.

Br J Dermatol. 2015 Mar;172(3):793-7. doi: 10.1111/bjd.13440. Epub 2015 Feb 5. No abstract available.

PMID:
25456748
42.

Non-anaplastic peripheral T-cell lymphoma in children and adolescents--a retrospective analysis of the NHL-BFM study group.

Kontny U, Oschlies I, Woessmann W, Burkhardt B, Lisfeld J, Salzburg J, Janda A, Attarbaschi A, Niggli F, Zimmermann M, Reiter A, Klapper W.

Br J Haematol. 2015 Mar;168(6):835-44. doi: 10.1111/bjh.13216. Epub 2014 Nov 14.

PMID:
25395120
43.

Whole exome sequencing hints at a unique mutational profile of paediatric T-cell lymphoblastic lymphoma.

Bonn BR, Huge A, Rohde M, Oschlies I, Klapper W, Voss R, Makarova O, Rossig C, Jürgens H, Seggewiss J, Burkhardt B.

Br J Haematol. 2015 Jan;168(2):308-13. doi: 10.1111/bjh.13105. Epub 2014 Aug 27. No abstract available.

PMID:
25160903
44.

Primary central nervous system lymphoma in children and adolescents: low relapse rate after treatment according to Non-Hodgkin-Lymphoma Berlin-Frankfurt-Münster protocols for systemic lymphoma.

Thorer H, Zimmermann M, Makarova O, Oschlies I, Klapper W, Lang P, von Stackelberg A, Fleischhack G, Worch J, Juergens H, Woessmann W, Reiter A, Burkhardt B.

Haematologica. 2014 Nov;99(11):e238-41. doi: 10.3324/haematol.2014.109553. Epub 2014 Aug 8. No abstract available.

45.

Recurrent RHOA mutations in pediatric Burkitt lymphoma treated according to the NHL-BFM protocols.

Rohde M, Richter J, Schlesner M, Betts MJ, Claviez A, Bonn BR, Zimmermann M, Damm-Welk C, Russell RB, Borkhardt A, Eils R, Hoell JI, Szczepanowski M, Oschlies I, Klapper W, Burkhardt B, Siebert R; German ICGC MMML-Seq-Project; NHL-BFM Study Group.

Genes Chromosomes Cancer. 2014 Nov;53(11):911-6. doi: 10.1002/gcc.22202. Epub 2014 Jul 8.

PMID:
25044415
46.

Primary EBV-positive Hodgkin's lymphoma of the CNS under azathioprine treatment: case report and review of the literature.

Henkenberens C, Franzke A, Raab P, Oschlies I, Klapper W, Christiansen H.

Strahlenther Onkol. 2014 Sep;190(9):847-52. doi: 10.1007/s00066-014-0670-9. Epub 2014 May 14. Review.

PMID:
24823896
47.

[Malignant lymphomas in children and adolescents. Practical knowledge for diagnosis].

Oschlies I, Klapper W.

Pathologe. 2014 Jul;35(4):383-95; quiz 396-7. doi: 10.1007/s00292-014-1891-5. Review. German.

PMID:
24780951
48.

A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma.

Salaverria I, Martin-Guerrero I, Wagener R, Kreuz M, Kohler CW, Richter J, Pienkowska-Grela B, Adam P, Burkhardt B, Claviez A, Damm-Welk C, Drexler HG, Hummel M, Jaffe ES, Küppers R, Lefebvre C, Lisfeld J, Löffler M, Macleod RA, Nagel I, Oschlies I, Rosolowski M, Russell RB, Rymkiewicz G, Schindler D, Schlesner M, Scholtysik R, Schwaenen C, Spang R, Szczepanowski M, Trümper L, Vater I, Wessendorf S, Klapper W, Siebert R; Molecular Mechanisms in Malignant Lymphoma Network Project; Berlin-Frankfurt-Münster Non-Hodgkin Lymphoma Group.

Blood. 2014 Feb 20;123(8):1187-98. doi: 10.1182/blood-2013-06-507996. Epub 2014 Jan 7.

49.

Early assessment of minimal residual disease identifies patients at very high relapse risk in NPM-ALK-positive anaplastic large-cell lymphoma.

Damm-Welk C, Mussolin L, Zimmermann M, Pillon M, Klapper W, Oschlies I, d'Amore ES, Reiter A, Woessmann W, Rosolen A.

Blood. 2014 Jan 16;123(3):334-7. doi: 10.1182/blood-2013-09-526202. Epub 2013 Dec 2.

PMID:
24297868
50.

[Primary Hodgkin's lymphoma of the colon].

Hansen T, Hartmann F, Hiller W, Schütz M, Oschlies I.

Pathologe. 2014 Mar;35(2):191-5. doi: 10.1007/s00292-013-1790-1. German.

PMID:
23793289

Supplemental Content

Loading ...
Support Center